Molecular mechanisms and therapeutic targets for diabetic kidney disease

Area of Science:

• Nephrology
• Endocrinology
• Molecular Medicine

Background:

• Diabetic kidney disease (DKD) is a major cause of kidney failure and cardiovascular events globally.
• Existing therapies leave a substantial residual risk of DKD progression.
• Understanding DKD's molecular drivers is crucial for developing novel treatments.

Purpose of the Study:

• To review the molecular mechanisms underlying diabetic kidney disease (DKD) onset and progression.
• To highlight the roles of inflammatory and fibrotic mediators in DKD pathophysiology.
• To discuss emerging therapeutic strategies for DKD.

Main Methods:

• Literature review of existing evidence on DKD molecular drivers.
• Focus on inflammatory and fibrotic pathways.
• Analysis of recent clinical trial results and dietary strategies.

Main Results:

• Diabetes-related metabolic disturbances initiate DKD, triggering metabolic, hemodynamic, inflammatory, and fibrotic processes.
• Inflammatory and fibrotic mediators play key roles in DKD progression.
• Recent trials show promise for new drug therapies and dietary interventions.

Conclusions:

• Targeting inflammatory and fibrotic mediators offers a promising therapeutic avenue for diabetic kidney disease (DKD).
• Novel drug therapies and dietary strategies are emerging as effective treatments for DKD.
• Further research into molecular mechanisms is essential to reduce DKD progression and associated risks.